Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced ATG and Mini PTCy for GVHD Prevention in Haplo-HSCT
NCT06984536Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- May 2025
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, cyclophosphamide in acute leukemia, myelodysplastic syndrome (MDS), sponsored by Peking University People's Hospital. Started May 2025; status: recruiting.
02
Drugs
antithymocyte globulin rabbitcyclophosphamide
03
Conditions
acute leukemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT06984536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06984536.